Search bioRxiv⌕ Search

Biology subjects

Girman, P.

Publications and source records attributed to Girman, P..

2 recordsLinked to original sources

Heterogeneity in cell-cycle dynamics of synthetic mRNA-induced β-cell proliferation

Adult pancreatic {beta}-cells are mostly locked in quiescence, limiting large-scale analysis of their cell cycle. To overcome this limitation, we used synthetic in vitro transcribed mRNAs encoding Cyclin D1 and CDK4 to induce proliferation in up to 70% of primary rat {beta}-cells. Flow cytometry-based analysis of cell-cycle markers revealed substantial heterogeneity in {beta}-cell cell-cycle progression, identifying five distinct groups of proliferating {beta}-cells based on G1 entry timing. Total cell-cycle length ranged from approximately 26 to 34 hours and was primarily determined by variability in G1 duration (13-19 hours). In the fastest-dividing {beta}-cells, G1, S, and G2M lasted approximately 13, 6, and 7 hours, respectively, whereas later-entering {beta}-cells exhibited progressively longer G1 phase. Additionally, we identified a small {beta}-cell subpopulation that failed to complete division and may have exited the cell cycle. These findings reveal cell-cycle entry and G1 progression as a major source of heterogeneity in {beta}-cell proliferation and provide quantitative benchmark for developing strategies to enhance controlled {beta}-cell regeneration in diabetes.

cell biology↗

Stimulation of rodent and human beta-cell proliferation using synthetic modified mRNAs encoding cell cycle regulators

Pancreatic beta cells exhibit marked resistance to proliferation, posing a barrier to therapeutic strategies aimed at restoring beta-cell mass in diabetes. Here, we present a transient, non-integrative approach to stimulate beta-cell proliferation using in vitro transcribed (IVT) mRNAs encoding cell cycle regulators. In rodent beta cells and human-beta cell derived EndoC-BH5 cells, chemically modified IVT mRNAs activated cell cycle entry and subsequent mitosis. A single dose of cyclin D1 and CDK4 IVT mRNAs nearly doubled the number of rat beta cells. However, achieving cell division in human beta cells required co-delivery of MYC IVT mRNA. The mitogenic response of beta cells peaked within 36-60 hours, and declined thereafter, reflecting the transient nature of IVT mRNA. Transcriptomic profiling revealed temporary activation of proliferative pathways and reversible downregulation of beta-cell maturation markers. Importantly, we detected no evidence of sustained proliferation. Our findings demonstrate that mRNA-based delivery of cell cycle regulators can overcome the intrinsic cell cycle block in beta cells and may provide a controllable approach for beta-cell regeneration.

bioengineering↗